mk 0663 has been researched along with Osteoarthritis, Knee in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, C; Sun, Y; Wang, C | 1 |
| Akhverdyan, YR; Polyakova, JV; Sivordova, LE; Zavodovsky, BV | 1 |
| Benson, HAE; Moss, P; Will, R; Wright, A | 1 |
| Baek, HJ; Bin, SI; Cho, YJ; Cukrow, DM; Kang, SB; Kim, SS; Lee, SW; Mehta, A; Min, BW; Moon, KH; Moon, SH; Park, YW; Shim, SC; Skuban, A; Song, YW; Vandormael, K; Yan, L; Yoo, DH; Yoo, MC; Yoo, WH | 1 |
| Arendt-Nielsen, L; Egsgaard, LL; Petersen, KK | 1 |
| Bingham, CO; Bird, SR; Smugar, SS; Tershakovec, AM; Xu, X | 1 |
| Lesaffre, E | 2 |
| Derry, S; Gammaitoni, AR; Moore, OA; Moore, RA; Peloso, PM; Wang, H | 1 |
| Bingham, CO; Smugar, SS; Tershakovec, AM; Wang, H | 1 |
| Fokter, SK; Repse-Fokter, A | 1 |
| Bockow, B; Curtis, S; DeTora, L; Fisher, C; Geissler, L; Gertz, BJ; Gottesdiener, K; Ko, A; Markenson, J; Schnitzer, T | 1 |
| Feldman, D; Gerli, R; Hou, SM; Ozturk, ZE; Rodger, IW; Scott, D; Uebelhart, D; Zacher, J | 1 |
| Bingham, CO; Bird, S; Fitzgerald, BJ; Kremer, J; O'Brien, K; Rubin, BR; Ruoff, GE; Sebba, AI; Smugar, SS; Tershakovec, AM | 1 |
| Bhattacharyya, TK; Das, N; Ghosh, S; Paul, S | 1 |
| Beaulieu, A; Castro, R; Detora, LM; Gallacher, AE; Leung, AT; Malmstrom, K; Ng, J; Poor, G; Sanchez, M; Sarembock, B | 1 |
3 review(s) available for mk 0663 and Osteoarthritis, Knee
| Article | Year |
|---|---|
Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
Topics: Aged; Analysis of Variance; Celecoxib; Cyclooxygenase Inhibitors; Etoricoxib; Female; Health Status Indicators; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Treatment Outcome | 2008 |
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
Topics: Cyclooxygenase 2 Inhibitors; Diffusion of Innovation; Dose-Response Relationship, Drug; Etoricoxib; Humans; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain; Pain Measurement; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Treatment Outcome | 2010 |
Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo.
Topics: Aged; Celecoxib; Cyclooxygenase 2 Inhibitors; Epidemiologic Methods; Etoricoxib; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Prognosis; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Time Factors; Treatment Outcome | 2009 |
9 trial(s) available for mk 0663 and Osteoarthritis, Knee
| Article | Year |
|---|---|
[Evidence of feasibility etoricoxib therapy in osteoarthritis in elderly patients].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diclofenac; Drug Monitoring; Etoricoxib; Female; Humans; Male; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Management; Pyridines; Sulfones; Treatment Outcome | 2016 |
Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial.
Topics: Aged; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Hyperalgesia; Locomotion; Male; Middle Aged; Neuralgia; Osteoarthritis, Knee; Pain Measurement; Pyridines; Sulfones | 2017 |
Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
Topics: Adult; Aged; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Pyridines; Republic of Korea; Sulfonamides; Sulfones; Treatment Outcome | 2014 |
Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis.
Topics: Aged; Central Nervous System Sensitization; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Pain Threshold; Pyridines; Sulfones; Treatment Outcome | 2016 |
Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Etoricoxib; Female; Health Status; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Pliability; Pyridines; Severity of Illness Index; Sulfones; Treatment Outcome | 2002 |
A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Pyridines; Sulfones; Treatment Outcome; United States | 2003 |
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Male; Middle Aged; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Pyrazoles; Pyridines; Severity of Illness Index; Sulfonamides; Sulfones; Thrombosis; Treatment Outcome | 2007 |
A study on the effects of diclofenac sodium and etoricoxib in the treatment of osteoarthritis.
Topics: Adult; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pyridines; Sulfones; Treatment Outcome | 2007 |
Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
Topics: Cyclooxygenase 2; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Etoricoxib; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Prostaglandin-Endoperoxide Synthases; Pyridines; Safety; Sulfones; Treatment Outcome | 2002 |
5 other study(ies) available for mk 0663 and Osteoarthritis, Knee
| Article | Year |
|---|---|
Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Drug Therapy, Combination; Etoricoxib; Female; Glucosamine; Humans; Inflammation Mediators; Male; Middle Aged; Osteoarthritis, Knee; Treatment Outcome | 2020 |
[Paracetamol in knee and hip arthrosis is dispensable].
Topics: Acetaminophen; Diclofenac; Etoricoxib; Humans; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Pyridines; Sulfones; Treatment Outcome | 2016 |
Use and misuse of the p-value.
Topics: Biomedical Research; Celecoxib; Cyclooxygenase Inhibitors; Etoricoxib; Humans; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Sample Size; Statistics as Topic; Sulfonamides; Sulfones | 2008 |
Superiority, equivalence, and non-inferiority trials.
Topics: Celecoxib; Cyclooxygenase Inhibitors; Etoricoxib; Humans; Myocardial Infarction; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Statistics as Topic; Sulfonamides; Sulfones; Thrombolytic Therapy; Treatment Outcome | 2008 |
Acute gouty arthritis in a patient after total knee arthroplasty.
Topics: Acute Disease; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthroplasty, Replacement, Knee; Diagnosis, Differential; Drug Therapy, Combination; Etoricoxib; Follow-Up Studies; Gout Suppressants; Humans; Male; Osteoarthritis, Knee; Postoperative Complications; Pyridines; Sulfones | 2010 |